SELPERCATINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where SELPERCATINIB was used for Neoplasm malignant.
Most Reported Side Effects for SELPERCATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 106 | 9.8% | 31 | 32 |
| Death | 90 | 8.3% | 88 | 1 |
| Hypertension | 58 | 5.4% | 1 | 18 |
| Hypersensitivity | 55 | 5.1% | 4 | 34 |
| Diarrhoea | 54 | 5.0% | 10 | 19 |
| Fatigue | 51 | 4.7% | 2 | 16 |
| Rash | 49 | 4.5% | 2 | 17 |
| Hepatic function abnormal | 42 | 3.9% | 3 | 21 |
| Alanine aminotransferase increased | 38 | 3.5% | 4 | 19 |
| Pyrexia | 38 | 3.5% | 1 | 18 |
| Aspartate aminotransferase increased | 37 | 3.4% | 4 | 17 |
| Ascites | 33 | 3.0% | 3 | 7 |
| Dry mouth | 32 | 3.0% | 5 | 10 |
| Electrocardiogram qt prolonged | 32 | 3.0% | 1 | 18 |
| Thrombocytopenia | 31 | 2.9% | 5 | 16 |
Other Indications for SELPERCATINIB
Non-small cell lung cancer (231)
Product used for unknown indication (214)
Lung neoplasm malignant (158)
Medullary thyroid cancer (116)
Thyroid cancer (59)
Lung adenocarcinoma (50)
Non-small cell lung cancer stage iv (23)
Lung adenocarcinoma stage iv (20)
Lung carcinoma cell type unspecified stage 0 (19)
Non-small cell lung cancer metastatic (18)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)